With great excitement and pride, 360biolabs is thrilled to announce the official opening of its new purpose-built facility, strategically located within the Alfred Precinct in Melbourne, Victoria. This advanced facility positions 360biolabs at the heart of The Alfred Research Alliance, Australia's largest centralized research, clinical trials, and hospital site.

The Alfred Research Alliance is a powerhouse of collaboration, bringing together eight esteemed members, including:

• Three universities: Monash University, La Trobe University, and Deakin University
• Two world-leading medical research institutes: Burnet Institute and Baker Heart and Diabetes Institute
• Two clinical research trial experts: 360biolabs and Nucleus Network
• One health service: Alfred Health, the core of this collaborative environment

Through this robust collaboration, the Alliance boasts world-leading experts in virtually every field of biomedical, translational, clinical, and public health research, as well as in education and healthcare. Together, these members are dedicated to thinking in new and innovative ways, translating the latest advances in medical research into new and improved diagnoses, treatments, and disease prevention strategies. Their combined efforts are focused on delivering the best possible clinical care and health outcomes.

The expansion of 360biolabs into this cutting-edge facility marks a significant milestone in the company’s ongoing commitment to advancing global innovation and supporting its mission of enabling future medicines. The state-of-the-art laboratory space will enhance the company’s capabilities in delivering high-quality clinical trial services, further solidifying its position as a leader in the field.

“We are honored to be a part of The Alfred Research Alliance and excited about the opportunities this new facility brings,” said spokesperson at 360biolabs. “Our presence within this prestigious hub of research and clinical excellence will enable us to collaborate with some of the brightest minds in the industry and contribute to groundbreaking advancements in medical research.”

The new facility is expected to drive innovation, foster collaboration, and accelerate the translation of scientific discoveries into real-world healthcare solutions.

360biolabs looks forward to celebrating this momentous occasion with the community and sharing more details about the grand opening of the new facility in the near future.